Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04682288 · ClinicalTrials.gov registry record · Phase 1
Levofloxacin Ocular Implant for Ocular Surgery
A Phase 1 study, sponsored by PolyActiva Pty.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT04682288: Completed Phase 1 study, sponsored by PolyActiva Pty.
NCT04682288 is a Phase 1 study that has completed, run by PolyActiva Pty. The registered enrollment target is 5 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04682288, a Phase 1 study, has completed, sponsored by PolyActiva Pty.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a multi center, open label, interventional study in one eye of 5 subjects scheduled for uncomplicated cataract surgery with administration of a single Levofloxacin Ocular Implant in the posterior sulcus of the surgical eye at the end of cataract surgery.
Primary Outcome
Change assessed according to Standardization of Uveitis Nomenclature (SUN) Grading Scale
Interventions
- DRUG Levofloxacin Ocular Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-01-04 |
| Est. Completion | 2021-10-14 |
| Phase | Phase 1 |
What the finished NCT04682288 record still lists
NCT04682288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which Levofloxacin Ocular Implant is the first listed.
NCT04682288 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04682288 about?
NCT04682288 is a clinical study titled "Levofloxacin Ocular Implant for Ocular Surgery". This is a multi center, open label, interventional study in one eye of 5 subjects scheduled for uncomplicated cataract surgery with administration of a single Levofloxacin Ocular Implant in the posterior sulcus of the surgical eye at the end of cataract surgery.
What is the current status of trial NCT04682288?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2021-01-04. Estimated completion is 2021-10-14.
What interventions are being tested in trial NCT04682288?
The interventions under investigation include: Levofloxacin Ocular Implant (DRUG).
Who is sponsoring clinical trial NCT04682288?
This trial is sponsored by PolyActiva Pty, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04682288's enrollment target sits among peer trials
5 1989th of 2000 higher than 6 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI